Menu

Top Stories

Published on Friday, May 10, 2019

Celebration of Life 2019: “Alpha-1 Derby: Betting on the cure”

Celebration of Life 2019: “Alpha-1 Derby: Betting on the cure”

On Monday, April 29th, the Alpha-1 Foundation welcomed friends, family, physicians, researchers, and industry partners to the 19th Annual Celebration of Life, the Foundation’s signature fundraising event in Miami Beach, Florida. The event is held annually to always remember to celebrate life and to raise funds for Alpha-1 Antitrypsin Deficiency (Alpha-1) research and programs.

Photo (left to right): Jeanine D'Armiento, MD, PhD, chair of the board; Fred Walsh, treasurer; Mark Brantly, MD; Miriam O'Day, president & CEO.

Guests arrived in their “derby-best” attire with colorful hats, seersucker and linen suits, and of course, bow ties. Attendees got to recreate the classic Kentucky Derby in a tropical Miami setting filled with fun, friendship, collaboration, and of course, horse racing. Guests “Bet on a Cure” while making playful bets on one of the sponsored horses with names like “We Scream for Ice Cream” and “Onna Mission”. Congratulations to Robert Sandhaus, MD, PhD, for sponsoring the winning horse, “Dot’s Delight.” The event raised $350,000!

“It is so nice to gather with so many good friends of the Alpha-1 Foundation at this beautiful venue for our Annual Celebration of Life, The Alpha-1 Derby. I would like to thank all attendees for their commitment towards the Foundation and the Alpha-1 community. What a wonderful way to have fun in our hats and bow ties to support this great cause,” said Miriam O’Day, president and CEO of the Alpha-1 Foundation. Joined by Jeanine D’Armiento, chair of the board of directors of the Foundation, the program included updates and appreciation to the event presenting sponsors. 

Fred Walsh, board of directors treasurer and brother of the late John W. Walsh presented the 2019 Ron Fraser MVP Award for the Most Valuable Philanthropist to Mark Brantly, MD, for his outstanding philanthropic vision and tireless dedication to the Foundation’s mission.

“Thank you, from the bottom of my heart, to the Alpha-1 Foundation for this recognition. It was many years ago that I met a very passionate individual named John Walsh that had a rare genetic condition, a vision, and an incredible drive to move things forward. My deepest gratitude to the Foundation and the Alpha-1 community for the opportunity to serve you. I look forward to the years ahead and to finding the cure for Alpha-1,” said Brantly, followed by a standing ovation.

"My wife, Lorraine, is the Alpha. Our entire family has come a long way, from disbelief to accepting, to 'let's go out and do all we can'. It is a learning process we all go through,"  said Joe Caporaso, an Alpha-1 volunteer who attended the event with his wife and Alpha, Lorraine.

"Being at this Celebration of Life event has shown me that the fight is on-going and people are willing to help find a cure in whatever way they can. Some through research, monetary donation, or giving of their time, but the bottom line for everyone is... To find a cure," he added.

"It is truly heartwarming and encouraging, as an Alpha, to see the wonderful support first hand. I was quite touched!" said Lorraine.

"I feel empowered the more I am part of the momentum for efforts to raise funds and awareness, as with this outstanding Derby event," she concluded.

Golf Classic Winners:

  • 1st place winners: Danny Alcantara, Alex DeLeon, Bobby Cohen, Robert DeLeon
  • Longest drive winners:  Dan Beltrani  and Lorna Nemcek 
  • Closest-to-hole winners: Alex DeLeon 

The Alpha-1 Foundation would like to thank our generous presenting sponsors: AlphaNet, CSL Behring, EVERSANA, Grifols, Takeda, Ruth and Gordon Cadwgan, PhD, and Lorna and Adrian Nemcek.

The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improving the lives of people affected by Alpha-1 worldwide.


Print

DNA data shared in ways patients may find surprising

Tuesday, August 13, 2019
Deals between drugmakers and hospital systems to mine the genetic profiles of hospital patients are triggering concerns over the control of valuable genetic data. Drugmakers have been spending hundreds of millions of dollars for access to...
Divider

Arrowhead Pharmaceuticals doses first patient in SEQUOIA Phase 2/3 Study of ARO-AAT for treatment of Alpha-1 liver disease

Thursday, August 8, 2019
Arrowhead Pharmaceuticals Inc. announced that it has dosed the first patient in SEQUOIA (AROAAT2001), a potentially pivotal Phase 2/3 clinical study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference...
Divider

CSL Behring announcement on their product Zemaira

Tuesday, August 6, 2019
Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency (Alpha-1). “CSL Behring...
Divider

The 28th Annual Alpha-1 National Conference: The Alpha of Tomorrow

Tuesday, July 23, 2019
Orlando, Florida was the site of the largest gathering of Alphas, caregivers, family members, researchers, industry representatives, and the Alpha-1 community in the world, as the Alpha-1 Foundation held its 28th Annual Alpha-1 National...
Divider

Save the date: Developing Therapeutics for Alpha-1 Antitrypsin Deficiency Workshop

Friday, July 19, 2019
The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are sponsoring the workshop entitled "Developing Therapeutics for Alpha-1 Antitrypsin Deficiency." The federal agencies will distribute a formal...
Divider

Alpha-1 Foundation earns highest not-for-profit accreditations

Monday, July 15, 2019
The Alpha-1 Foundation earned the 2019 Platinum Seal of Transparency, the highest level of recognition offered by GuideStar, the world’s largest database and source of nonprofit information, and received a 4-star rating from Charity...
Divider

Two years have passed since the liver transplant surgery that saved Jude Ward’s life

Thursday, July 11, 2019
Almost two years have passed since Nicole and Josef Ward’s son, Jude, had a liver transplant due to Alpha-1 Antitrypsin Deficiency (Alpha-1). You can read that story by clicking here. Most people diagnosed with Alpha-1 don’t exhibit...
Divider

Dicerna to begin clinical development of DCR-A1AT for treatment of patients with Alpha-1-associated liver disease

Monday, July 8, 2019
Dicerna Pharmaceuticals, Inc. announced it submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA) to conduct a first-in-human Phase 1/2 study of DCR-A1AT, an investigational therapy from the...
Divider

FDA grants fast track to Alpha-1-related liver disease drug

Friday, June 28, 2019
Arrowhead Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ARO-AAT, the company’s second-generation subcutaneously administered RNA interference (RNAi) therapeutic being...
Divider

Watch the 28th Annual Alpha-1 National Conference from home

Tuesday, June 18, 2019
The Annual Alpha-1 National Conference is the largest annual gathering of Alphas, their families, leading healthcare professionals, including researchers, physicians, scientists, respiratory therapists, nurse practitioners, and industry...
Divider

The Annual Alpha-1 National Conference: The largest gathering of Alphas

Tuesday, June 18, 2019
The city of Orlando, Florida, will be the site of the largest gathering of Alphas, caregivers, family members, researchers, industry representatives, and the Alpha-1 community at large, as the Alpha-1 Foundation holds its 28th Annual Alpha-1...
Divider

CSL Behring initiates voluntary recall for 4 lots of Zemaira

Thursday, June 6, 2019
The Alpha-1 Foundation was informed by CSL Behring that a Voluntary Biological Product Recall is being initiated for 4 lots of Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive